Syngene Expands Integrated Drug Development and Manufacturing Services with BMS

Summary

Syngene and Bristol Myers Squibb have expanded their integrated drug development and manufacturing collaboration, building on their partnership that began in 1998 and established the Biocon Bristol Myers Squibb Research and Development Center.